Press Releases
-
ClearNote Health’s Avantect® Test Selected for World’s Largest Study of Pancreatic Cancer Detection in High-Risk Patient Population
ClearNote Health's Avantect Pancreatic Cancer test was selected for a large UK NHS study that will include up to 15,000 patient participants recently diagnosed with type 2 diabetes. The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer.
Dec 17, 2024
-
Oxford Nanopore, Action for ME, and University of Edinburgh launch groundbreaking study into the genetics of ME
Oxford Nanopore Technologies will participate in a groundbreaking study will analyse the entire genetic code of up to 17,000 people with Myalgic Encephalomyelitis (ME) in a bid to uncover the genetic causes of the illness.
Dec 15, 2024
-
eClinical Solutions Collaborates with Snowflake to Streamline Data for Life Sciences
Integration between eClinical’s elluminate Clinical Data Cloud and Snowflake offers modern data architecture to power clinical data science and AI, unlock data value for healthcare outcomes
Dec 16, 2024
-
ENEA-Tech Biomedical Foundation invests €6m in BetaGlue® Therapeutics brings 2024 funding round total to €24m
BetaGlueBetaGlue announced today that the ENEA-Tech and Biomedical Foundation has invested €6m bringing the total raised in the current funding round to €24m.
Dec 15, 2024
-
VieCure’s Halo Intelligence Platform Adopted by Commonwealth Cancer Center
VieCure announced that Commonwealth Cancer Center will deploy its Halo Intelligence platform - the first AI-enabled community oncology care solution. Clinicians will use the platform to manage precision oncology data and help determine the optimal personalized treatment path for patients across rural Kentucky.
Dec 11, 2024
-
Coronado Research announce appointment of Dr Jennifer Bradford as VP, Head of Data Science
Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.
Dec 11, 2024
-
The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to Deploy Digital Pathology for Diagnostics in the Cloud with Amazon Web Services (AWS)
Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.
Dec 10, 2024
-
Symbiosis Expands Business Development Team with Two Key Commercial Appointments in the US
-
Ceryx Medical Initiates First-In-Human Study of the Cysoni™ RSA Pacemaker
Ceryx today announced that the first patient has been enrolled in the RSA-Pace multi-center study at Waikato Hospital in Hamilton, New Zealand.
Dec 8, 2024
-
Phastar Scoops Prestigious 2024 Scrip Award
Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.
Dec 8, 2024
-
Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market
Abselion has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.
Dec 3, 2024
-
Duke Street Bio Announces First Patient Dosed in Phase I Trial with DSB2455, a Next Generation PARP1 Selective Inhibitor for the Treatment of Solid Tumours
Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.
Dec 2, 2024
-
2BScientific Limited announces opening of a new European hub in Germany
2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and broadening the reach of its existing suppliers.
Nov 27, 2024
-
Huateng Pharma Provides PEG-Based Hydrogels for Medical Device Applications
-
Cold Chain Technologies Acquires Tower Cold Chain, Expanding its Product Portfolio and Global Service Network
-
Clinion Wins SCDM 2024 Innovation Award for Excellence in Clinical Data Science
Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.
Dec 1, 2024
-
India Charts BioE3 Policy to Propel Advanced Biomanufacturing
The government announced the BioE3 (Biotechnology for Economy, Environment and Employment) policy, a strategic plan to take India to the next era of industrialization through advanced biomanufacturing. Enhancing India’s biomanufacturing capabilities by integrating science, technology, engineering, and manufacturing will enable institutions, universities, startups, and industries in India to participate in innovation, thereby supporting the growth of the upstream bioprocessing market.
Nov 26, 2024
-
Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development
PhaseV's Machine Learning Platforms are Being Used by Top Global Pharma Companies to Guide Adaptive Trials, Precision Medicine, and Indication Selection Across Multiple Therapeutic Areas
Nov 24, 2024
-
Hovione Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland
-
Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs
Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.
Nov 24, 2024